Five Years of Ublituximab in Relapsing Multiple Sclerosis: Additional Results from Open-label Extension of ULTIMATE I and II Studies (P11-1.006)
Hari P. Miskin, Krzysztof Selmaj, Edward A. Fox, Derrick Robertson et al.
Journal
Neurology
Topics
Radiopharmaceutical Chemistry and Applications
article
Five Years of Ublituximab in Relapsing Multiple Sclerosis: Additional Results from Open-label Extension of ULTIMATE I and II Studies (P11-1.006)
Hari P. Miskin, Krzysztof Selmaj, Edward A. Fox, Derrick Robertson, Hans‐Peter Hartung, Enrique Álvarez, DeRen Huang, Daniel Wynn, Lawrence Steinman, Jackie Parker, Karthik Bodhinathan, Peter Sportelli, Bruce Cree, Christopher R. Rowland, Koby Mok, Peiqing Qian, Yanzhi Hsu, Sibyl Wray, Yihuan Xu
article en
Abstract
No abstract available for this paper.
Publication Tag
NeurologyVol. 104(7_Supplement_1)
Institutions
Memorial Hospital of South Bend (US), University of South Florida (US), Multiple Sclerosis Foundation (US), University of Colorado System (US), HOPE Clinic (US), Stanford Medicine (US), CDG Therapeutics (United States) (US), Heinrich Heine University Düsseldorf (DE), University of Warmia and Mazury in Olsztyn (PL)